SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-008597
Filing Date
2017-05-10
Accepted
2017-05-10 15:55:10
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20170331_10q.htm 10-Q 653473
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14212
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14027
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7000
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6673
  Complete submission text file 0001437749-17-008597.txt   3659717

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20170331.xml EX-101.INS 740087
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20170331.xsd EX-101.SCH 40120
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20170331_cal.xml EX-101.CAL 39887
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20170331_def.xml EX-101.DEF 277802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20170331_lab.xml EX-101.LAB 235103
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20170331_pre.xml EX-101.PRE 290260
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 17830083
SIC: 2834 Pharmaceutical Preparations